CTBO (Cantabio Pharmaceuticals) Research & Development: $0.39 Mil (TTM As of Dec. 2018)


What is Cantabio Pharmaceuticals Research & Development?

Cantabio Pharmaceuticals CTBO Research & Development is $0.39 Mil as of Dec. 2018.

Research & Development is the aggregate amount of research and development expenses during the year. Cantabio Pharmaceuticals's Research & Development for the three months ended in Dec. 2018 was $0.08 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2018 was $0.39 Mil.

Cantabio Pharmaceuticals  (OTCPK:CTBO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cantabio Pharmaceuticals Research & Development Related Terms

Cantabio Pharmaceuticals Research & Development Historical Data

* Premium members only.

The historical data trend for Cantabio Pharmaceuticals's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantabio Pharmaceuticals Research & Development Chart

Cantabio Pharmaceuticals Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Research & Development
Get a 7-Day Free Trial 0.00 0.01 0.15 0.35 0.37

Cantabio Pharmaceuticals Quarterly Data
Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.12 0.11 0.08 0.08

Cantabio Pharmaceuticals Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.39 Mil mean?
Cantabio Pharmaceuticals (CTBO) has a Research & Development of $0.39 Mil as of Dec. 2018. Research and development expense is the total cost for research and development activities. View historical data on Cantabio Pharmaceuticals and its competitors.
Is Cantabio Pharmaceuticals' Research & Development too high?
Cantabio Pharmaceuticals' current Research & Development is $0.39 Mil.
How does Cantabio Pharmaceuticals' Research & Development compare to TNTY and ETNI?
Cantabio Pharmaceuticals' Research & Development of $0.39 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Cantabio Pharmaceuticals and its competitors. Cantabio Pharmaceuticals's current Research & Development is $0.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantabio Pharmaceuticals stock overvalued right now?
Cantabio Pharmaceuticals (CTBO) has a current Research & Development of $0.39 Mil. The current Research & Development is $0.39 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Cantabio Pharmaceuticals (CTBO), the current Research & Development is $0.39 Mil as of Dec. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantabio Pharmaceuticals Business Description

Address 1250 Oakmead Parkway, Sunnyvale, CA, USA, 94085
Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.